Trexquant Investment LP

Position in HAE — Haemonetics Corp

CIK 1633445 STAMFORD, CT

Position in HAE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,287,043

+$2,226,295 QoQ

Shares Held

218,010

+73.7% QoQ

Ownership

0.480%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $264,507,021 across 41 Medical Devices names. HAE ranks #7 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	547,076	$43,809,846
2	SYK	Stryker Corp	75,199	$24,709,639
3	BSX	Boston Scientific Corp	385,491	$24,189,560
4	PODD	Insulet Corp	102,230	$21,451,943
5	DXCM	Dexcom Inc	304,067	$19,095,407
6	IRTC	iRhythm Holdings, Inc.	111,311	$13,136,924
7	HAE	Haemonetics Corp This page	218,010	$12,287,043
8	TMDX	TransMedics Group, Inc.	106,300	$10,567,283

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,287,043	218,010	+73.7%	Shares	Sole	2026-05-15
2025-12-31	$10,060,748	125,524	+14.5%	Shares	Sole	2026-02-17
2025-09-30	$5,344,097	109,645	+119.0%	Shares	Sole	2025-11-14
2025-06-30	$3,736,244	50,077	+251.2%	Shares	Sole	2025-08-12
2023-06-30	$1,213,926	14,258	-67.7%	Shares	Sole	2023-08-11
2023-03-31	$3,658,129	44,207	-32.1%	Shares	Sole	2023-05-15
2022-12-31	$5,120,193	65,101	+352.2%	Shares	Sole	2023-02-13
2022-09-30	$1,065,735	14,396	-88.6%	Shares	Sole	2022-11-14
2022-06-30	$8,241,294	126,439	+3604.6%	Shares	Sole	2022-08-11
2022-03-31	$215,769	3,413	-56.6%	Shares	Sole	2022-05-13
2021-12-31	$417,371	7,869	+168.8%	Shares	Sole	2022-02-14
2020-12-31	$347,700	2,928	-39.7%	Shares	Sole	2021-02-11
2020-09-30	$423,773	4,857	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.